DrugDashboards

loteprednol etabonate

loteprednol etabonate · LOTEPREDNOL ETABONATE 5 mg/mL · Suspension · Ophthalmic · Lupin Pharmaceuticals, Inc.

NDC 70748-0300-01 · 1 BOTTLE in 1 CARTON / 5 mL in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The generic price has fallen 48% in a year, to $10.53 per mL — and generics that get this cheap tend to get abandoned rather than defended. The brand (Inveltys) runs $103.18 per mL 6.4× more. One of its named manufacturing plants, Lupin Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$10.53per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$23.73per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00$30.00Sep 2025Sep 2026$10.53
13 price points · per MLSource: CMS NADAC

Medicaid spend (2025)

$11,301
93 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for loteprednol etabonate (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA215719
TE code
AB
Approval date
Apr 24, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of loteprednol etabonate (Suspension)

LabelerStrengthFirst seenLast seen
Alcon Laboratories, Inc.LOTEPREDNOL ETABONATE 10 mg/mLJul 15, 2026Sep 2, 2026
Alcon Laboratories, Inc.LOTEPREDNOL ETABONATE 10 mg/mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.LOTEPREDNOL ETABONATE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "loteprednol etabonate — NDC 70748-0300-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70748030001.

Free to cite with attribution — see how the data is put together.